XBiotech (XBIT)
(Delayed Data from NSDQ)
$6.74 USD
-0.05 (-0.74%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $6.79 +0.05 (0.74%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.74 USD
-0.05 (-0.74%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $6.79 +0.05 (0.74%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
The Zacks Analyst Blog Highlights Quince Therapeutics and XBiotech
by Zacks Equity Research
Quince Therapeutics and XBiotech are included in this Analyst Blog.
Don't Know Much Biology? Tips for Picking Microcap Biotech, Pharma
by Mark Zinski
Two microcap biotech stocks to consider for the science-challenged among us.
Stock Market News for Aug 25, 2020
by Zacks Equity Research
The S&P 500 and the Nasdaq hit an all-time high on Monday after news of a potential coronavirus treatment lifted investors' sentiment.
Why XBiotech Inc. (XBIT) Could Shock the Market Soon
by Zacks Equity Research
Solid estimate revisions and an impressive Zacks Rank suggest that better days may be ahead for XBiotech (XBIT) and that now might be an interesting buying opportunity.
XBiotech (XBIT) Catches Eye: Stock Moves Up 11.6% in Session
by Zacks Equity Research
XBiotech, Inc. (XBIT) moved big last session, as its shares rose over 11% on the day.